JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
JANX - Janux Therapeutics, Inc.
USD | NASDAQ | Healthcare
Summary
Summary JANX Stock
Financials
Financials JANX Stock
Loading...
Loading...
Income Statement
Income Statement JANX Stock
Balance Sheet
Balance Sheet JANX Stock
Cash Flow Statement
Cash Flow Statement JANX Stock
Loading...
Loading...
JANX Financials - Janux Therapeutics Income & Cash Flow | Ledgeburg
Home
Stocks
Janux Therapeutics, Inc. (JANX)
Financials
Financials of JANX
Loading...
Loading...
Loading...
Loading...
Revenue
$10M
Operating Income
$-157.667M
Net Income
$-113.625M
Share Count (Basic)
61.966999M
Operating Cash Flow
$-82.235M
Free Cash Flow
$-83.278M
Cash And Short-Term Equivalents
$966.567M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
2M
4M
6M
8M
10M
FY2021
FY2022
FY2023
FY2024
Revenue $USD
0
2M
4M
6M
8M
10M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Annual
Quarterly
Net Income $USD
-120M
-100M
-80M
-60M
-40M
Annual
Quarterly
Margins
Gross
Operating
Net
-1600%
-1400%
-1200%
-1000%
-800%
-600%
FY2025
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-34M
-32M
-30M
-28M
-26M
-24M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-1000%
-800%
-600%
-400%
-200%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26